The DDW Fall 2026 issue examines precision therapies for Parkinson's Disease, what the resurgence of neuroscience means for drug discovery and why cancer vaccines depend on DNA synthesis. Other features in the Fall issue include: From investment to innovation - why we've launched a new event series The three generations of obesity medications Rethinking paediatric oncology treatments Read More
The DDW Summer 2026 issue examines the multi-compound approach to autism, the outlook for GLP-1 therapies and highlights drug discovery innovators and investors - investment challenges and opportunities for drug developers. Other features in the Summer issue include: The importance of tech and collaboration for immunotherapies The challenges of cancer drug resistance Where the value of AI lies in drug discovery Read More
The DDW Spring issue explores the next phase of obesity medications and asks how US tariffs are impacting global pharma. It also looks at how India is scaling innovation in drug discovery and includes an exclusive guide in the advancements in cancer research. Other features in the Spring issue include: Advances in genomics drug discovery Data efforts in AI Advances in radiopharmaceuticals Read More
The DDW Winter 2025/2026 issue examines the advances and challenges in blood cancer drug development, how the Baltics is implementing a new action plan for its life sciences sectors, and how spatial epigenetics is unlocking new frontiers for drug discovery. Other features in the Winter issue include: What to expect from drug discovery in 2026 Are active immunotherapies the key to Alzheimer’s? The legal implications of AI in drug discovery Read More
The DDW Fall issue examines why there is a need for a universal pneumococcal vaccine, why China might be the next global biopharma powerhouse and looks at developments in microbiome research and the therapeutic sectors it is driving. It also features an exclusive guide exploring how AI is driving advancements in drug discovery. Other features in the Fall issue include: How creativity and open science are transforming drug repurposing How to harness innovation for drug discovery The promise of gene therapies in Alzheimer’s Read More
The DDW Summer issue includes in-depth features on the technologies and advancements driving genomics drug discovery, how supercomputing can drive neuroscience discoveries, and everything you need to know about spatial biology. Other features in the Summer issue include: A market report on the the European biotech sector How molecular precision can enable GLP-1 therapies How AI is enabling true drug design Read More
The DDW Spring issue explores the breakthroughs occurring in Huntington’s disease, looks at the challenges facing endometriosis drug development and highlights how quantum computing can advance drug discovery research. Other features in the Spring issue include: A market report on the US biotech hubs driving drug discovery The unmet need for fibrosis treatments and emerging treatment opportunities AI and the future of cell therapies Read More
The DDW Winter issue asks why sex and gender need to be recognised is drug discovery, explores the drug discovery trends we’re expected to see in 2025, and features an exclusive supplement covering what’s on at SLAS2025. Other features in the Winter issue include: How to prepare for the next infectious disease pandemic Navigating the landscape of immunotherapy Pushing past the limitations of CAR-T therapies Read More
The DDW Fall issue asks if the gut microbiome can unlock new therapeutics for mental health disorders, places a spotlight on oncology, and includes an exclusive guide on the benefits and advances in cell line development. Other features in the Fall issue include: Beyond CRISPR–what anew tool offers gene editing How the UK could become a leader in cannabinoid research How mRNA’s tiny cousin could treat thousands of rare diseases Read More
The DDW Summer issue looks at where the global biotech hubs are for drug discovery and development, asks how 3D genomics can accelerate personalised medicine, and looks at the technological advances in mass spectrometry. It also includes an exclusive global cancer research guide examining the innovation happening in this sector. Read More
The DDW Spring issue looks at where we are in the fight against antimicrobial resistance, explores how structural biology is informing vaccine design, and offers advice on approaching dealmaking in biopharma. It also includes an exclusive cell and gene therapy guide examining the innovation happening in this sector. Read More
The DDW Winter issue asks whether AI can deliver better immunotherapies for cancer and includes expert predictions on what to expect from the sector in 2024, alongside a supplement looking at SLAS2024 and an exclusive guide exploring therapeutic antibodies. Read More
This issue features a focus on Biomarkers and NGS as well as a market report on the UK’s drug discovery sector, advances in Spatial Biology, and a discussion on the sustainable lab. Read More
This issue features a Therapeutic Spotlight on Immuno-oncology as well as a market report on India’s drug discovery sector, advancing treatments in Alzheimer’s, and whether big data can chart a new path to drug discovery and development. Other features of the Summer 2023 issue include an exclusive guide on the therapeutic antibody market which outlines where the innovation and opportunity is in this market and how it is evolving. Read More
The Spring 2022 issue of DDW combines the latest innovation, business-critical content and analysis in drug discovery and development. Articles cover using animal genomics to find human therapies and exploring the microbiome Read More
The DDW Winter Issue includes an overview of the drug discovery landscape in 2023, sector successes and challenges in the Scandinavian market, and the first in the DDW Guide series on cell & gene therapy. Read More
